Although COVID-19 testing led to a spike in total Medicare Part B spending on clinical diagnostic laboratory testing in 2020, spending on all other testing significantly declined in the [...]
The American Hospital Association and American Medical Association have joined with health care systems and independent providers in filing suit against the U.S. Department of Health and Human Services [...]
Update 12/10/21: On December 9, the Senate passed legislation to delay for one year the next round of cuts to laboratory reimbursement and the associated private-payer data reporting period [...]
At the start of the COVID-19 pandemic, each state and the federal government announced various states of public health emergencies which enabled them to suspend or modify various laws, [...]
On October 6, 2021, California Governor Gavin Newson signed into law bill SB535. This bill restricts health insurers from requiring prior authorizations to limit advanced cancer patients’ timely access [...]
A letter dated September 23, 2021 from Cigna says, “As a result of a recent review, we will deny separate reimbursement for Current Procedural Terminology (CPT®) codes billed with [...]
The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the sequestration payment adjustment percentage of 2% applied to all Medicare Fee-for-Service (FFS) claims from May 1 through December [...]
The quarterly update for clinical laboratory fee schedule (CLFS) and laboratory services subject to reasonable charge payment information is now available. For information on the data reporting period and [...]
The process for registering patients for billing of COVID-19 testing to the HRSA payer is currently backlogged. The patient registration process was returning ID numbers within a day or [...]
UnitedHealthcare is delaying the implementation of the clinical and pathology Laboratory Test Registry Protocol until further notice. This includes registration of non-genetic tests and placement of test codes on claims [...]